First nasal medication to treat anaphylactic reactions

First nasal medicine to treat anaphylactic reactions

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has approved Eurneffy (epinephrine) for use in the European Union. This medicine is the first to be administered through the nose to treat anaphylactic reaction emergencies and offers new hope for those suffering from severe allergies. Read more here

If you need more information about regulatory services, ELS can certainly help.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.